Lilly disappointed with their Alzheimers trial today and that makes LGVN and other small cap Alzheimers plays look more attractive in my opinion.
I am expecting some data to come in for LGVN this month. I can see it pulling a SAVA type move if the data is good. Albeit it's only phase 1 so who knows
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.